Leukemia

In this video, Andrew Hantel, MD, discusses the results of a study he helped present at ASCO Annual Meeting researching inequities in acute myeloid leukemia treatment in historically marginalized communities.

In this video, Christine McMahon, MD, discusses the results of a randomized trial of a care model for patients with acute myeloid leukemia and myelodysplastic syndrome, presented at ASCO Annual Meeting.

In this video, Christine McMahon, MD, discusses the results of the phase 3 ASC4FIRST study, pertaining to chronic myelogenous leukemia, presented at ASCO Annual Meeting.

CHICAGO — Telemedicine substantially reduced greenhouse gas emissions associated with travel to in-person clinical visits for cancer care, results from a retrospective study presented at ASCO Annual Meeting showed.

Adults with chronic lymphocytic leukemia under active surveillance had a significantly longer treatment-free survival period if they took vitamin D supplements, results from a retrospective study published in Blood Advances showed.

Editor’s note: This is the first in a series of five stories from ASCO Voices, a session during the 2024 ASCO Annual Meeting focused on the human side of oncology.

CHICAGO — Asciminib demonstrated superior efficacy to standard first-line therapies for certain patients with newly diagnosed chronic myeloid leukemia, according to study results presented at ASCO Annual Meeting.

Researchers have discovered the mechanisms by which the chemotherapy drug ponatinib harms the heart.

Individuals with low-risk chronic lymphocytic leukemia who exhibit no symptoms may no longer require specialized follow-up, according to study data published in Blood Advances.

Use of immune checkpoint inhibitors for pregnant women with cancer may be safer than previously thought, according to study results published in JAMA Network Open.